The absence of GM-CSF autoantibodies excluded the autoimmune form of PAP, while genetic testing identified a homozygous mutation in the CSF2RA gene, confirming the hereditary form [9]. This evidence concerns the gene CSF2RA and pulmonary alveolar proteinosis.